Power and sample size assessments for tests of hypotheses on cost-effectiveness ratios

Health Economics

Volumn 9, Issue 3, 2000, Pages 227-234

  Gardiner, Joseph C ^a   Huebner, Marianne ^b   Jetton, James ^a   Bradley, Cathy J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Bivariate normal distribution; Confidence interval; Cost effectiveness analysis; Power; Sample size

Indexed keywords

ARTICLE; CONFIDENCE INTERVAL; COST BENEFIT ANALYSIS; DRUG SCREENING; ECONOMICS; HUMAN; METHODOLOGY; NORMAL DISTRIBUTION; QUALITY ADJUSTED LIFE YEAR; SAMPLE SIZE; STATISTICAL MODEL; STATISTICS; COST EFFECTIVENESS ANALYSIS; PRIORITY JOURNAL; RESOURCE ALLOCATION; STATISTICAL ANALYSIS;

CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; DRUG EVALUATION; HUMANS; MODELS, ECONOMETRIC; NORMAL DISTRIBUTION; QUALITY-ADJUSTED LIFE YEARS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 0033624760     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1050(200004)9:3<227::AID-HEC509>3.0.CO;2-Z     Document Type: Article

References (19)

1. O'Brien, B.J., Drummond, M.F., Labelle, R.J. and Willan, A. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Medical Care 1994; 32: 150-163.
2. Van Hout, B.A., Al, M.J., Gordon, G.S. and Rutten, F.F.H. Cost, effects and C/E ratios alongside a clinical trial. Health Economics 1994; 3: 309-319.
3. Wakker, P. and Klassen, M.P. Confidence intervals for cost/effectiveness ratios. Health Economics 1995; 4: 373-381.
4. Gardiner, J.C., Hogan, A., Holmes-Rovner, M., Rovner, D., Griffith, L. and Kupersmith, J. Confidence intervals for cost-effectiveness ratios. Medical Decision Making 1995; 15: 254-263.
5. Willan, A.R. and O'Brien, B.J. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. Health Economics 1996; 5: 297-305.
6. Chaudhary, M.A. and Stearns, S.C. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Statistics in Medicine 1996; 15: 1447-1458.
7. Laska, E., Meisner, M. and Siegel, C.S. Statistical inference for cost-effectiveness ratios. Health Economics 1997; 6: 229-242.
8. Briggs, A.H., Wonderling, D.E. and Mooney, C.Z. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Economics 1997; 6: 327-340.
9. Gardiner, J.C., Holmes-Rovner, M., Goddeeris, J., Rovner, D. and Kupersmith, J. Covariate-adjusted cost-effectiveness ratios. Journal of Statistical Planning & Inference 1999; 75: 291-304.
10. Briggs, A.H. and Gray, A.M. Power and sample size calculations for cost-effectiveness studies. Medical Decision Making 1998; 18 (Suppl): S81-S92.
11. Al, M.J., Van Hout, B.A., Michel, B.C. and Rutten, F.F.H. Sample size calculations in economic evaluations. Health Economics 1998; 7: 327-335.
12. Laska, E., Meisner, M. and Siegel, C.S. Power and sample size in cost-effectiveness analysis. Medical Decision Making 1999; 19: 339-343.
13. Polsky, D., Glick, H.A., Willke, R. and Schulman, K. Confidence intervals for cost-effectiveness ratios: a comparison of four methods. Health Economics 1997; 6: 243-252.
14. Tambour, M., Zethraeus N. and Johannesson, M. A note on confidence intervals in cost-effectiveness analysis. International Journal of Technology Assessment in Health Care 1998; 14: 467-471.
15. Sacristán, J.A., Day, S.J., Navarro, O., Ramos, J. and Hernandez, J.M. Use of confidence intervals and sample size calculations in health economic studies. Annals of Pharmacotherapy 1995; 29: 719-725.
16. Gold, M.R., Siegel, J.E., Russell, L.B. and Weinstein, M.C. (Eds). Cost effectiveness in health and medicine. New York: Oxford University Press, 1996.
17. Van den Hout, W.B. and Kievit, J. Statistical inference and sample sizes for cost-effectiveness analyses. Abstract, 19th Annual Meeting of the Society for Medical Decision Making, Houston, TX, 1997.
18. Willan, A.R. and O'Brien B.J. Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data. Health Economics 1999; 8: 203-211.
19. Mullahy, J. What you don't want to know can't hurt you? Statistical issues and standards for medical technology evaluation. Medical Care 1996; 34: DS124-DS135.